Premium
Letter to the Editor: No Baclofen for Alcohol Use Disorders Even More When Liver Disease Is Serious!
Author(s) -
Braillon Alain,
Naudet Florian
Publication year - 2019
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.30575
Subject(s) - baclofen , medicine , acamprosate , abstinence , harm , alcohol use disorder , clinical trial , alcohol dependence , naltrexone , psychiatry , psychology , alcohol , opioid , chemistry , biochemistry , receptor , agonist , social psychology